Cyxtera (CYXT) Stock Forecast, Price Target & Predictions
CYXT Stock Forecast
Cyxtera stock forecast is as follows: an average price target of $6.35 (represents a 9669.23% upside from CYXT’s last price of $0.07) and a rating consensus of 'Buy', based on 4 wall street analysts offering a 1-year stock forecast.
CYXT Price Target
CYXT Analyst Ratings
Cyxtera Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Feb 07, 2023 | - | Credit Suisse | $5.00 | $2.62 | 90.84% | 7592.31% |
Dec 22, 2022 | - | Truist Financial | $6.00 | $1.81 | 231.49% | 9130.77% |
Dec 14, 2022 | - | BNP Paribas | $2.00 | $2.00 | - | 2976.92% |
Dec 01, 2022 | - | Citigroup | $2.75 | $1.96 | 40.31% | 4130.77% |
Sep 20, 2022 | - | Truist Financial | $15.00 | $4.65 | 222.58% | 22976.92% |
Jun 08, 2022 | Greg Miller | Truist Financial | $20.00 | $14.33 | 39.57% | 30669.23% |
Jun 06, 2022 | Jonathan Atkin | RBC Capital | $16.00 | $14.82 | 7.96% | 24515.38% |
Cyxtera Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | - | - |
Avg Price Target | - | - | - |
Last Closing Price | $0.07 | $0.07 | $0.07 |
Upside/Downside | -100.00% | -100.00% | -100.00% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Feb 07, 2023 | Credit Suisse | Outperform | Outperform | Hold |
Dec 14, 2022 | Exane BNP Paribas | - | Underperform | Initialise |
Dec 01, 2022 | Citigroup | Buy | Buy | Hold |
Aug 24, 2022 | Citigroup | - | Buy | Upgrade |
Jun 06, 2022 | RBC Capital | Outperform | Outperform | Hold |
Jan 03, 2022 | UBS | - | Neutral | Initialise |
Cyxtera Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
CYXT | Cyxtera | $0.07 | $6.35 | 8971.43% | Buy |
NOTE | FiscalNote | $0.85 | $7.25 | 752.94% | Buy |
ALYA | Alithya Group | $1.13 | $3.50 | 209.73% | Hold |
BBAI | BigBear.ai | $1.61 | $3.00 | 86.34% | Buy |
NABL | N-able | $12.37 | $17.00 | 37.43% | Buy |
CTLP | Cantaloupe | $9.16 | $11.00 | 20.09% | Buy |
INOD | Innodata | $20.64 | $23.00 | 11.43% | Buy |
G | Genpact | $38.78 | $42.25 | 8.95% | Hold |
PRFT | Perficient | $75.96 | $81.00 | 6.64% | Hold |
GDYN | Grid Dynamics | $15.62 | $13.00 | -16.77% | Buy |
EXLS | ExlService | $42.12 | $32.64 | -22.51% | Buy |
SASI | NextTrip | $4.15 | $2.00 | -51.81% | - |
CYXT Forecast FAQ
Is Cyxtera a good buy?
Yes, according to 4 Wall Street analysts, Cyxtera (CYXT) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 3 'Buy' recommendations, accounting for 75.00% of CYXT's total ratings.
What is CYXT's price target?
Cyxtera (CYXT) average price target is $6.35 with a range of $2 to $16, implying a 9669.23% from its last price of $0.065. The data is based on 4 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Cyxtera stock go up soon?
According to Wall Street analysts' prediction for CYXT stock, the company can go up by 9669.23% (from the last price of $0.065 to the average price target of $6.35), up by 24515.38% based on the highest stock price target, and up by 2976.92% based on the lowest stock price target.
Can Cyxtera stock reach $0?
CYXT's average twelve months analyst stock price target of $6.35 supports the claim that Cyxtera can reach $0 in the near future.